4.3 Article

Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 146, Issue 1-2, Pages 144-152

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2003.11.004

Keywords

multiple sclerosis; experimental autoinumme encephalomyelitis; males; androgens; testosterone

Funding

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050839] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036680, R01NS045443] Funding Source: NIH RePORTER
  3. NIAID NIH HHS [AI50839] Funding Source: Medline
  4. NICHD NIH HHS [HD07228] Funding Source: Medline
  5. NINDS NIH HHS [NS45443, NS36680] Funding Source: Medline

Ask authors/readers for more resources

A gender difference prevails in some murine strains of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS). Our results showed that castration of SJL males, a strain characterized by decreased susceptibility of males as compared to females, displayed increased disease severity. In contrast, castration had no effect on disease in C57BL/6 males, a strain in which no gender difference in EAE is observed. Regardless of whether endogenous androgens were protective in a given genetic background, supplemental androgen treatment was protective in gonadally intact males of both strains. These data provide a basis for the novel therapeutic use of supplemental testosterone for men with MS. (C) 2003 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available